Catheter Precision, Inc.

Flyte, a regional air mobility company, announced full-scale activation of its Memorial Day flight network across the Northeast corridor, deploying aircraft on high-frequency short-haul routes including NYC to Nantucket, Hamptons, and Martha's Vineyard. The company aims to capture premium travel demand during the holiday weekend surge by offering...

Flyte, a regional air mobility subsidiary of Catheter Precision Inc. (VTAK), is expanding operations to capitalize on major airlines' strategic retreat from short-haul routes due to rising fuel costs and unfavorable economics. The company operates Cirrus Vision Jets under FAA Part 135 certification, positioning itself to fill the connectivity gap...

Catheter Precision, Inc. (VTAK) announced its attendance at the European Heart Rhythm Association (EHRA) conference in Paris from April 12-14, 2026. The company will showcase its LockeT suture retention device, which recently received CE Mark approval, and its VIVO 3D imaging system for identifying ventricular arrhythmia origins. CEO David Jenkin...

Catheter Precision (VTAK) has completed the acquisition of the remaining 80.02% equity interest in Fly Flyte Inc. from Creatd Inc. (CRTDD), achieving 100% ownership of the regional aviation operator. The transaction converts Flyte into a wholly owned operating subsidiary with certified aircraft, FAA Part 135 certification, and active revenue-gene...

Catheter Precision, Inc. (NYSE American: VTAK) announced that its LockeT suture retention device will be featured in live procedural cases at the International Symposium of Left Atrial Appendage 2026 conference in Los Angeles. The device, a Class I FDA-registered and CE Mark-approved suture retention device for wound closure after percutaneous ve...